GENERAL (Schedule of Reclassifications out of AOCI) (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| Financial income | $ (2,480) | $ 3,595 | $ (1,896) | $ 5,005 |
| Cost of revenues | 145,172 | 89,033 | 275,446 | 165,411 |
| Research and development, net | 19,551 | 12,725 | 37,426 | 24,183 |
| Sales and marketing | 15,954 | 11,961 | 32,159 | 22,736 |
| General and administrative | 5,776 | 3,265 | 10,465 | 7,704 |
| Total, before income taxes | 38,185 | 22,710 | 79,533 | 36,124 |
| Income tax expense (benefit) | 3,617 | 186 | 9,279 | (575) |
| Total, net of income taxes | 34,568 | 22,524 | 70,254 | 36,699 |
| Unrealized gains on cash flow hedges, net [Member] | Amount Reclassified from Accumulated Other Comprehensive Loss [Member] | ||||
| Cost of revenues | 108 | 166 | ||
| Research and development, net | 363 | 570 | ||
| Sales and marketing | 92 | 151 | ||
| General and administrative | 82 | 153 | ||
| Total, before income taxes | 645 | 1,040 | ||
| Income tax expense (benefit) | (46) | (46) | ||
| Total, net of income taxes | $ 599 | $ 994 | ||
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|